SelectQuote, Inc. (NYSE:SLQT) Short Interest Update

SelectQuote, Inc. (NYSE:SLQT - Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 1,570,000 shares, a drop of 33.8% from the January 31st total of 2,370,000 shares. Approximately 1.2% of the shares of the stock are sold short. Based on an average trading volume of 1,730,000 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Noble Financial raised shares of SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $4.00 price target on shares of SelectQuote in a research note on Friday, November 22nd.

Insider Buying and Selling at SelectQuote

In other news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total value of $272,000.00. Following the completion of the transaction, the insider now owns 1,166 shares of the company's stock, valued at approximately $6,343.04. This represents a 97.72 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.40% of the company's stock.

Remove Ads

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Creative Planning grew its stake in SelectQuote by 6.6% in the third quarter. Creative Planning now owns 100,019 shares of the company's stock valued at $217,000 after acquiring an additional 6,150 shares during the period. KCM Investment Advisors LLC acquired a new stake in SelectQuote in the 3rd quarter valued at $608,000. Connor Clark & Lunn Investment Management Ltd. increased its stake in SelectQuote by 17.1% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 623,548 shares of the company's stock valued at $1,353,000 after purchasing an additional 91,071 shares in the last quarter. Intech Investment Management LLC bought a new stake in SelectQuote during the 3rd quarter valued at $123,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in SelectQuote by 4.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,181,663 shares of the company's stock worth $2,564,000 after buying an additional 53,159 shares during the last quarter. 34.59% of the stock is owned by institutional investors and hedge funds.

SelectQuote Trading Down 0.6 %

Shares of SelectQuote stock traded down $0.03 on Wednesday, hitting $4.00. The stock had a trading volume of 1,359,797 shares, compared to its average volume of 1,249,162. The stock has a 50 day moving average of $4.44 and a 200 day moving average of $3.29. The firm has a market capitalization of $687.72 million, a P/E ratio of -44.39 and a beta of 1.15. SelectQuote has a twelve month low of $1.48 and a twelve month high of $6.86. The company has a debt-to-equity ratio of 2.10, a quick ratio of 6.36 and a current ratio of 6.36.

SelectQuote (NYSE:SLQT - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. Sell-side analysts expect that SelectQuote will post -0.07 earnings per share for the current fiscal year.

About SelectQuote

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.